Energy drinks can be dangerous for the adolescent heart
Overconsumption poses risks for arrhythmias and other cardiovascular events, per study in Canadian Journal of Cardiology
By Eileen Leahy Posted on 2 April 2015
The rapid rise in popularity of energy drinks (EDs), particularly among adolescents (aged 10-19 years) and young adults, has serious implications for cardiac health. In an article published in the Canadian Journal of Cardiology, researchers focus on the pharmacology of EDs, adverse reactions to them, and how the marketing of these drinks as a means to relieve fatigue and improve physical and cognitive performance may be ignoring real dangers.
An international research team led by Fabian Sanchis-Gomar, PhD, MD, of the Research Institute of Hospital 12 de Octubre in Madrid, noted that EDs can trigger sudden cardiac deaths in young, apparently healthy individuals. For persons with underlying heart diseases, the risk of triggering sudden arrhythmic death syndrome (SADS) or other arrhythmias can be significant. Even atrial fibrillation (AF), normally uncommon in children without structural heart disease, has been observed in a 13-year-old adolescent boy during a soccer training session after ingesting EDs.
It is estimated that 31 percent of 12- to 19-year old adolescents regularly consume energy drinks. These beverages often contain high amounts of labeled caffeine. However, they can contain “masked” caffeine, in the form of guarana, for example, which comes from a Brazilian plant and is identical to caffeine found in coffee beans but at twice the concentration. The addition of guarana and other substances, such as ginseng and taurine, in variable quantities may generate uncertain interactions.
Although caffeine is widely used and generally regarded as safe, serious adverse effects have been reported, especially when consumed in larger doses. With a range of readily available sources, such as EDs, gums, inhalers and orodispersable sheets, adolescents and young adults can easily overdose. It is estimated that as many as 46 percent of the 5,448 caffeine overdoses reported in the United States in 2007 occurred in adolescents younger than 19 years.
Possible manifestations of energy drink abuse in adolescents
- Atrial fibrillation or flutter
- Ventricular arrhythmias
- QT prolongation
- ST-segment elevation
- Increased anxiety and depression
- Shortness of breath
- Loss of control and a feeling of imminent death
- Development of uncontrollable phobias and fears
- Increased platelet aggregation
- Decreased endothelial function
- Myocardial infarction
- Hemodynamic failure
- Sudden cardiac death
- Cumulative cardiovascular load
- Cerebral blood flow reduction
Source: Sanchis-Gomar, et al, Canadian Journal of Cardiology (May 2015)
Dr. Sanchis-Gomar and his co-investigators, Dr. Pareja-Galeano (Universidad Europea de Madrid), Dr. Cervellin, Dr. Lippi (Academic Hospital of Parma), and Dr. Earnest (Texas A&M University), caution that:
- One can (250 mL) of an ED per day is safe for most healthy adolescents.
- ED consumption before or during sports practice should be avoided.
- Adolescents with clinically relevant underlying medical conditions should consult cardiologists before drinking EDs.
- Excessive ED consumption together with alcohol or other drugs, or both, may lead to adverse effects, including death.
“As ED consumption continues to grow, physicians are advised to ask adolescent patients whether they consume EDs, to be aware of the symptoms of ED overconsumption, and to discuss the dangers of EDs alone and mixed with alcohol,” explained Dr. Sanchis-Gomar. “It is important for physicians to understand the lack of regulation in caffeine content and other ingredients of these high-energy beverages and their complications so that parents and children can be educated about the risk of cardiac arrhythmias and the potential development of anxiety and phobias accompanying excessive ED consumption.”
The authors also urge that concerns should be communicated to parents and educators, who may be inadvertently guilty of promoting overconsumption of caffeine.
Read the study
Elsevier has made this article freely available for 30 days, until May 1, 2015:
Fabian Sanchis-Gomar, PhD, MD, Helios Pareja-Galeano, PhD, Gianfranco Cervellin, MD, Giuseppe Lippi, MD, and Conrad P. Earnest, PhD: "Energy Drink Overconsumption in Adolescents: Implications for Arrhythmias and Other Cardiovascular Events," Canadian Journal of Cardiology (May 2015)
The Canadian Journal of Cardiology is the official journal of the Canadian Cardiovascular Society. It is a vehicle for the international dissemination of new knowledge in cardiology and cardiovascular science, particularly serving as a major venue for the results of Canadian cardiovascular research and Society guidelines. The journal publishes original reports of clinical and basic research relevant to cardiovascular medicine as well as editorials, review articles, case reports, and papers on health outcomes, policy research, ethics, medical history, and political issues affecting practice. The journal is published by Elsevier.
Elsevier Connect Contributor
Eileen Leahy has handled media outreach for 14 years for a portfolio of Elsevier Health Sciences journals, including the American Journal of Preventive Medicine, Mayo Clinic Proceedings and The American Journal of Medicine. An experienced STM journal marketer, Eileen was responsible for the launches of numerous journals while on staff at Elsevier, most notably, the Journal of the American College of Cardiology and Gastroenterology. She continues working as an independent consultant specializing in the development and marketing of innovative online full-text publications.
By Rodney E. Rohde, PhD, David M. Falleur, MEd, and Joanna R. Ellis, MS | Posted on 10 Mar 2015
Your barber, realtor, electrician and massage therapist are all licensed, but only 12 states in the US license medical laboratoriansBy Eileen Leahy | Posted on 29 Jan 2015
In Mayo Clinic Proceedings, experts urge drastic reductions in the consumption of added sugarsBy Brian H. Chon, MD | Posted on 25 Nov 2014
The difference between conventional X-ray therapy and proton therapy – and why we are re-examining the way we treat left-side breast cancerBy Craig Smith | Posted on 14 Nov 2014
Majority of primary care physicians lack confidence in screening patients for HCV, survey findsBy Liz Smith | Posted on 23 Oct 2014
I assumed I would cry; I surprised myself by laughingBy Mary Beth O'Leary | Posted on 04 Jun 2013
Stem Cell Reports is the new open-access journal of the International Society for Stem Cell Research (ISSCR), published by Cell PressBy The Lancet Press Office | Posted on 16 May 2013
New study in The Lancet looks at trial combining the bone-building drug teriparatide with denosumab, a targeted therapy to stop bone loss